Explore comprehensive CDMO services offered by Chengdu Shengnuo Biopharm Co Ltd, supporting end-to-end Anlaytical Testing, Drug Development, Manufacturing and Packaging. Chengdu Shengnuo Biopharm Co Ltd enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China, Pakistan, U.S.A
Description: Founded in 2004, Chengdu Shengnuo Biopharma is a leading Chinese manufacturer specializing in peptide and amino acid drugs. The company integrates R&D, production, and sales across four core areas: peptide APIs, CDMO services, cosmetic peptides, and peptide formulations. Shengnuo operates 25 cGMP-compliant production lines, with an annual API production capacity exceeding 3 tons. Its manufacturing capabilities span five dosage forms, including injectables, lyophilized powders, and solid preparations. Several products are certified by major regulatory bodies such as the U.S. FDA, EU EDQM, South Korea MFDS, and Mexico Cofepris, and are exported to over 30 countries. The company has developed commercial-scale production technologies for 50+ peptide drugs, with kilogram-scale single-batch API production. - Show More
